Dr. Michael Joseph Demeure, MD

Dr. Demeure practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Demeure's NPI, 1629041579, was assigned on February 10, 2006. Dr. Demeure graduated from Drexel University College Of Medicine in 1983. Dr. Demeure holds California license G64786.

Dr. Demeure's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Demeure also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Demeure's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Demeure to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demeure practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Demeure's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Demeure is board certified in certified physician executive by the American Association Physician Leaders. Dmand AI has Dr. Demeure's licenses on file in 4 states: California, Arizona, Wisconsin and Pennsylvania.

Dmand AI lists thyroid surgery among the conditions Dr. Demeure treats.

CMS data shows 253 Medicare services from Dr. Demeure across 6 procedure codes in 2024, for 120 Medicare patients. Medicare paid $28,992 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Demeure in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demeure's median patient age at 63, with 74% women.

In 2024, Dr. Demeure wrote 115 Medicare Part D claims for 51 patients. 90% of them were for generic drugs. CMS names the drug for 86 of them, across 2 drugs with 11 or more claims each, at $578 in total drug cost. In 2023, CMS named 62 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Demeure for performance year 2024, reported as part of a group. Dr. Demeure accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 83 papers to Dr. Demeure, published from 2010 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Pancreatic Neoplasms, Adrenal Cortex Neoplasms and Biomarkers, Tumor. Dr. Demeure has published most often in Surgery. Dr. Demeure's most frequent co-authors are Daniel Douglas Von Hoff, MD, Steven Arthur Ahrendt, MD and David R. Braxton, MD.

Dmand AI links Dr. Demeure to 7 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Medullary, Thyroid Cancer, Papillary and Adenocarcinoma, Follicular.

CMS Open Payments shows 63 general payments to Dr. Demeure from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Eli Lilly and Company paid the most, $27,000.

Dmand AI lists 2 awards for Dr. Demeure.

Dr. Demeure graduated from Drexel University College Of Medicine in 1983. Dr. Demeure is a member of AACE, ACS and ASCO.

Dr. Demeure is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.